These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 2760468)
21. Hybridoma generation by in vitro immunization of murine splenocytes with cytosolic proteins of Chinese hamster ovary (CHO) mitotic cells. Ravi M; Sundar SS; Kumar KK; Parvathi D; Paul SF Hybridoma (Larchmt); 2007 Oct; 26(5):311-5. PubMed ID: 17979547 [TBL] [Abstract][Full Text] [Related]
22. Intrasplenic primary immunization for the production of monoclonal antibodies. Spitz M; Spitz L; Thorpe R; Eugui E J Immunol Methods; 1984 May; 70(1):39-43. PubMed ID: 6609209 [TBL] [Abstract][Full Text] [Related]
23. Production of murine monoclonal antibodies against sulcofuron and flucofuron by in vitro immunisation. Bonwick GA; Cresswell JE; Tyreman AL; Baugh PJ; Williams JH; Smith CJ; Armitage R; Davies DH J Immunol Methods; 1996 Sep; 196(2):163-73. PubMed ID: 8841454 [TBL] [Abstract][Full Text] [Related]
24. A method of generating antibodies against exogenously administered self-antigen by manipulating CD4+CD25+ regulatory T cells. Iwanari H; Nakada-Nakura Y; Kusano-Arai O; Suzuki N; Kodama T; Sakihama T; Hamakubo T J Immunol Methods; 2011 Jun; 369(1-2):108-14. PubMed ID: 21570402 [TBL] [Abstract][Full Text] [Related]
25. Production of mouse monoclonal antibodies against human HLA-A3 for use in microlymphocytotoxicity technique. Yari F; Sareh S; Sadri A; Sharifi Z; Najafi F Hum Antibodies; 2009; 18(3):119-22. PubMed ID: 19729806 [TBL] [Abstract][Full Text] [Related]
26. The generation of monoclonal antibodies against human pancreatic exocrine cancer: a study of six different immunisation regimes. Grant AG; Harris PM; Heyderman E; Larkin SE; Pym B; Hermon-Taylor J Br J Cancer; 1985 Oct; 52(4):543-50. PubMed ID: 4063133 [TBL] [Abstract][Full Text] [Related]
27. Production of BSF-1 during an in vivo, T-dependent immune response. Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779 [TBL] [Abstract][Full Text] [Related]
28. Parameters involved in the in vitro immunization of tonsilar lymphocytes: effects of rIL-2 and muramyl dipeptide. Carroll K; Prosser E; O'Kennedy R Hybridoma; 1990 Feb; 9(1):81-9. PubMed ID: 2312133 [TBL] [Abstract][Full Text] [Related]
29. Increased yield of antibody-producing murine spleen cell hybridomas from fusions cultured in medium supplemented with mouse serum. Persson MA; Lerner RA J Immunol Methods; 1990 Feb; 127(1):39-42. PubMed ID: 2319141 [TBL] [Abstract][Full Text] [Related]
30. In vitro B-lymphocyte antigen priming against both non-immunogenic and immunogenic molecules requiring low amounts of antigen and applicable in hybridoma technology. Brams P; Pettijohn DE; Brown M; Olsson L J Immunol Methods; 1987 Apr; 98(1):11-22. PubMed ID: 2435806 [TBL] [Abstract][Full Text] [Related]
31. A simple standardised protocol for the production of monoclonal antibodies against viral and bacterial antigens. Coyle PV; Wyatt D; McCaughey C; O'Neill HJ J Immunol Methods; 1992 Aug; 153(1-2):81-4. PubMed ID: 1517605 [TBL] [Abstract][Full Text] [Related]
32. Analysis of cellular phenotype during in vitro immunization of murine splenocytes for generating antigen-specific immunoglobulin. Inagaki T; Yoshimi T; Kobayashi S; Kawahara M; Nagamune T J Biosci Bioeng; 2013 Mar; 115(3):339-45. PubMed ID: 23177212 [TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies to feline lymphocyte membranes recognize the leukocyte-common antigen (CD45R). Masuoka K; Toyosaki T; Tohya Y; Norimine J; Kai C; Mikami T J Vet Med Sci; 1992 Oct; 54(5):865-70. PubMed ID: 1420566 [TBL] [Abstract][Full Text] [Related]
34. Mimicking the humoral immune response in vitro results in antigen-specific isotype switching supported by specific autologous T helper cells: generation of human HIV-1-neutralizing IgG monoclonal antibodies from naive donors. Chin LT; Malmborg AC; Kristensson K; Hinkula J; Wahren B; Borrebaeck CA Eur J Immunol; 1995 Mar; 25(3):657-63. PubMed ID: 7535699 [TBL] [Abstract][Full Text] [Related]
35. Culture conditions that optimize outgrowth of hybridomas. Hamilton MJ; Davis WC Methods Mol Biol; 1995; 45():17-28. PubMed ID: 7550679 [No Abstract] [Full Text] [Related]
36. Monoclonal antibodies against Vi antigen production and characterization. Pieńkowska D; Kunikowska D; Głośnicka R Bull Inst Marit Trop Med Gdynia; 1993-1994; 44-45(1-4):89-93. PubMed ID: 7580356 [TBL] [Abstract][Full Text] [Related]
37. Monoclonal Antibodies Production Against a 40KDa Band of Hydatid Cyst Fluid. Sharafi SM; Shirzad H; Khanahmad H; Ataei B; Darani HY Recent Pat Biotechnol; 2018; 12(1):57-64. PubMed ID: 28317492 [TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibody against human interleukin 2 (IL 2). I. Purification of IL 2 for the production of monoclonal antibodies. Stadler BM; Berenstein EH; Siraganian RP; Oppenheim JJ J Immunol; 1982 Apr; 128(4):1620-4. PubMed ID: 6977565 [TBL] [Abstract][Full Text] [Related]
39. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies. White J; Haskins KM; Marrack P; Kappler J J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566 [TBL] [Abstract][Full Text] [Related]
40. Spleen cell analysis and optimal immunization for high-frequency production of specific hybridomas. Stähli C; Staehelin T; Miggiano V Methods Enzymol; 1983; 92():26-36. PubMed ID: 6304456 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]